Clinical Trial Update: Instant Message-delivered Personalised Acceptance and Commitment Therapy (ACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment [NA]

View source ↗

Summary

An ongoing clinical trial in individuals with mild cognitive impairment evaluates an instant-message-delivered, personalized Acceptance and Commitment Therapy f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Instant Message-delivered Personalised Acceptance and Commitment Therapy

Snippet

Sponsor: The University of Hong Kong | Conditions: Mild Cognitive Impairment (MCI) | NA | Status: ENROLLING_BY_INVITATION